"Your Partner of Choice and your gate to the Middle East and North Africa (MENA) Pharmaceutical World"


Genpharm Services is a financially sound privately owned company based in the Dubai Biotechnology and Research Park (DuBiotech), U.A.E. We provide fast-track Market Access to specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. We focus on innovative and orphan drugs in areas of unmet medical needs, rare genetic disorders and autoimmune diseases.


We also provide Management Consultancy for companies aiming at expanding directly into this dynamic region of high growth. We advise on strategies, structures and operating business models in line with the respective company priorities and portfolio.

ASPIRE MS Research Grant in Middle East

As part of Genpharm/Genzyme commitment to support and expand MS research across the Middle East & North Africa region, it’s our pleasure to announce the launch of ASPIRE Grant during the 1st MENACTRIMS meeting in October 2014. The ASPIRE Grant is exclusively funded by Genpharm/Genzyme.

Gene Therapy: The Next Frontier in the Treatment of Genetic & Rare Disease.

Gene therapy is the use of genes as treatment for a genetic disease by directing the expression of a therapeutic protein or restoring the expression of a missing protein. It involves the transfer of a therapeutic or working gene copy into specific cells of an individual to repair a faulty gene copy or to introduce a new gene whose function is to cure or to favorably modify the clinical course of a condition.

ASPIRE Educational Series

Part of our commitment to patients and physicians across the MENA region, Genpharm is launching the first and only ASPIRE Educational Series focused on CNS and Neurological disorders, in collaboration with the online portal Kayf.TV The campaign is based on a broad range of educational videos and interviews with some of the most prominent neurologists in the field of clinical practice and research.

World Orphan Drug Congress - USA 2015

Genpharm is a proud sponsor of the 5th Annual World Orphan Drug Congress, to be held in Washington DC during April 22nd to 24th 2015. WODC is the premier commercial event for the global rare disease industry. World Orphan Drug Congress USA is packed with great content exploring clinical development, patient partnerships, regulatory approval, reimbursement, exploiting global trends, manufacturing, distribution, orphan drug business models and commercialization strategies.

White Paper

MENA Market: An Attractive Opportunity for Rare Disease and Healthcare Companies. Get your free copy by clicking on the Download button.

GENPHARM Services - Your Gateway to the MENA Pharmaceutical Market

We are a specialty pharmaceutical marketing and consulting company, providing our strategic partners with fast and sustainable market access into the MENA (Middle East & North Africa) region, including business development, in-licensing and more. We operate through evidence-based medicine and the highest ethical standards. Our expertise is based on an in-depth knowledge of the pharmaceutical market and the local business culture. Furthermore, our vast experience and the trusted network of partners allow us to deliver market opportunities for specialty, rare disease, biotech and innovative healthcare organizations.
The MENA region has been experiencing fast economic and sustainable GDP growth. This positive outlook is driven by several factors providing pharmaceutical companies with untapped regional opportunities...
The healthcare sector in the MENA region has been experiencing sustainable double digit growth. Driven by unmet medical needs and increased medical public awareness, governments have been heavily investing in both infrastructure and access
We operate through a holistic market approach. We manage all relevant stakeholders for our partners, including Physicians, Patient groups, distributors and payers. Our expertise include KOL management, advocacy and CME programs..
Genpharm Services is managed by highly experienced Pharma executives. The operations are led by staff with a strong track record in senior leadership roles in multinational pharmaceutical organizations...

Our Services

Latest News